AnthracyclinesNaphthacenesAntibiotics, AntineoplasticDaunorubicinDoxorubicinAclarubicinCarubicinIdarubicinEpirubicinBreast NeoplasmsRazoxaneNogalamycinAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsTaxoidsBridged CompoundsLeukemia P388DNA Topoisomerases, Type IIHeart DiseasesAconitic AcidVinblastineDrug Resistance, MultipleP-GlycoproteinDrug Resistance, NeoplasmAnthraquinonesDexrazoxaneChemotherapy, AdjuvantMitoxantronePaclitaxelReceptor, erbB-2CardiotoxinsFluorouracilDrug Administration ScheduleTreatment OutcomeCyclophosphamideDrug ResistanceLeukemia L1210Topoisomerase II InhibitorsAntineoplastic Agents, PhytogenicDisease-Free SurvivalDeoxycytidineNeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm MetastasisVerapamilStreptomycesDose-Response Relationship, DrugSalvage TherapyCytarabineLiposomesIntercalating AgentsEtoposideAlopeciaCardiomyopathiesVincristineHeartLeukotriene C4SurvivorsTumor Cells, CulturedDrug Screening Assays, AntitumorTrifluoperazineDrug InteractionsPhthalic AcidsEpothilonesInfusions, IntravenousAntigens, NeoplasmMitomycinLeukemia, Myeloid, AcuteAntibodies, Monoclonal, HumanizedMultidrug Resistance-Associated ProteinsCalreticulinCell SurvivalRemission InductionSurvival AnalysisMethotrexateGlycosidesPregnancy Complications, NeoplasticLactoperoxidaseStructure-Activity RelationshipCell Line, TumorCardiotonic AgentsLeukemia, Promyelocytic, Acute